Concepts (110)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Genome-Wide Association Study | 7 | 2023 | 100 | 1.650 |
Why?
|
| Genome, Human | 3 | 2020 | 24 | 0.880 |
Why?
|
| Language | 3 | 2021 | 13 | 0.850 |
Why?
|
| Gene Flow | 2 | 2021 | 9 | 0.810 |
Why?
|
| Demography | 1 | 2021 | 105 | 0.740 |
Why?
|
| Genetic Variation | 5 | 2021 | 169 | 0.690 |
Why?
|
| Polymorphism, Single Nucleotide | 7 | 2023 | 190 | 0.680 |
Why?
|
| Datasets as Topic | 2 | 2020 | 15 | 0.610 |
Why?
|
| Polymorphism, Genetic | 2 | 2019 | 96 | 0.580 |
Why?
|
| Genomics | 5 | 2022 | 106 | 0.580 |
Why?
|
| Population | 1 | 2016 | 5 | 0.570 |
Why?
|
| Genetics, Population | 6 | 2021 | 50 | 0.540 |
Why?
|
| Haplotypes | 5 | 2021 | 119 | 0.480 |
Why?
|
| Genetic Predisposition to Disease | 4 | 2023 | 168 | 0.440 |
Why?
|
| Human Migration | 2 | 2021 | 8 | 0.370 |
Why?
|
| HLA-DP beta-Chains | 2 | 2019 | 4 | 0.340 |
Why?
|
| INDEL Mutation | 2 | 2019 | 16 | 0.340 |
Why?
|
| Gene Frequency | 4 | 2021 | 117 | 0.310 |
Why?
|
| Humans | 16 | 2023 | 14077 | 0.300 |
Why?
|
| Esophageal Neoplasms | 1 | 2023 | 26 | 0.220 |
Why?
|
| Carcinoma, Squamous Cell | 1 | 2023 | 32 | 0.220 |
Why?
|
| Whole Genome Sequencing | 5 | 2021 | 40 | 0.220 |
Why?
|
| HLA Antigens | 1 | 2022 | 50 | 0.210 |
Why?
|
| South Africa | 8 | 2022 | 7312 | 0.200 |
Why?
|
| Glucuronosyltransferase | 1 | 2021 | 6 | 0.200 |
Why?
|
| Linguistics | 1 | 2021 | 5 | 0.190 |
Why?
|
| DNA, Ancient | 1 | 2021 | 3 | 0.190 |
Why?
|
| Chromosomes, Human, Y | 1 | 2021 | 9 | 0.190 |
Why?
|
| Antineoplastic Agents | 1 | 2021 | 61 | 0.190 |
Why?
|
| Interleukin-8 | 1 | 2021 | 21 | 0.190 |
Why?
|
| Geography | 1 | 2021 | 60 | 0.190 |
Why?
|
| Colorectal Neoplasms | 1 | 2021 | 47 | 0.190 |
Why?
|
| Health | 1 | 2020 | 11 | 0.190 |
Why?
|
| Arthritis, Rheumatoid | 1 | 2022 | 158 | 0.180 |
Why?
|
| Phylogeny | 1 | 2021 | 231 | 0.180 |
Why?
|
| Recombination, Genetic | 1 | 2019 | 27 | 0.170 |
Why?
|
| Adaptation, Biological | 1 | 2018 | 5 | 0.160 |
Why?
|
| Databases, Genetic | 1 | 2017 | 20 | 0.150 |
Why?
|
| Male | 4 | 2021 | 6489 | 0.140 |
Why?
|
| Human Genome Project | 1 | 2016 | 6 | 0.140 |
Why?
|
| Bias | 1 | 2016 | 12 | 0.140 |
Why?
|
| India | 1 | 2016 | 60 | 0.140 |
Why?
|
| Alleles | 3 | 2021 | 134 | 0.130 |
Why?
|
| Spinal Cord Regeneration | 1 | 2014 | 1 | 0.120 |
Why?
|
| Female | 3 | 2021 | 8751 | 0.110 |
Why?
|
| Anti-HIV Agents | 1 | 2021 | 1275 | 0.100 |
Why?
|
| Lipids | 2 | 2022 | 81 | 0.100 |
Why?
|
| History, Ancient | 2 | 2021 | 6 | 0.090 |
Why?
|
| Africa South of the Sahara | 2 | 2022 | 328 | 0.090 |
Why?
|
| Case-Control Studies | 2 | 2023 | 464 | 0.090 |
Why?
|
| Genetic Association Studies | 2 | 2019 | 11 | 0.090 |
Why?
|
| Histocompatibility Testing | 2 | 2019 | 26 | 0.080 |
Why?
|
| High-Throughput Nucleotide Sequencing | 2 | 2019 | 47 | 0.080 |
Why?
|
| Africa | 2 | 2020 | 360 | 0.080 |
Why?
|
| HIV Seropositivity | 2 | 2019 | 263 | 0.070 |
Why?
|
| HIV Infections | 1 | 2021 | 4946 | 0.050 |
Why?
|
| Genetic Pleiotropy | 1 | 2022 | 2 | 0.050 |
Why?
|
| Lim Kinases | 1 | 2022 | 4 | 0.050 |
Why?
|
| HLA-DRB1 Chains | 1 | 2022 | 17 | 0.050 |
Why?
|
| Sex Characteristics | 1 | 2022 | 43 | 0.050 |
Why?
|
| Chromatin | 1 | 2022 | 2 | 0.050 |
Why?
|
| Phenotype | 1 | 2022 | 144 | 0.050 |
Why?
|
| Antineoplastic Agents, Phytogenic | 1 | 2021 | 9 | 0.050 |
Why?
|
| Up-Regulation | 1 | 2021 | 23 | 0.050 |
Why?
|
| Quality Control | 1 | 2021 | 27 | 0.050 |
Why?
|
| Phytohemagglutinins | 1 | 2021 | 9 | 0.050 |
Why?
|
| Computational Biology | 1 | 2021 | 43 | 0.050 |
Why?
|
| Liver | 1 | 2021 | 74 | 0.050 |
Why?
|
| Linkage Disequilibrium | 1 | 2021 | 40 | 0.050 |
Why?
|
| Oxazines | 1 | 2021 | 71 | 0.050 |
Why?
|
| Piperazines | 1 | 2021 | 73 | 0.050 |
Why?
|
| Monocytes | 1 | 2021 | 27 | 0.050 |
Why?
|
| Leukocytes, Mononuclear | 1 | 2021 | 60 | 0.050 |
Why?
|
| HIV-1 | 2 | 2019 | 1239 | 0.050 |
Why?
|
| Africa, Southern | 1 | 2021 | 89 | 0.050 |
Why?
|
| Heterocyclic Compounds, 3-Ring | 1 | 2021 | 76 | 0.050 |
Why?
|
| Pyridones | 1 | 2021 | 87 | 0.050 |
Why?
|
| Metabolism | 1 | 2020 | 3 | 0.050 |
Why?
|
| Immunity | 1 | 2020 | 10 | 0.050 |
Why?
|
| DNA Repair | 1 | 2020 | 11 | 0.050 |
Why?
|
| Genetics, Medical | 1 | 2020 | 21 | 0.050 |
Why?
|
| Selection, Genetic | 1 | 2020 | 31 | 0.050 |
Why?
|
| Cholesterol, LDL | 1 | 2022 | 137 | 0.050 |
Why?
|
| Genotype | 1 | 2021 | 430 | 0.040 |
Why?
|
| 5' Untranslated Regions | 1 | 2019 | 7 | 0.040 |
Why?
|
| Genetic Carrier Screening | 1 | 2019 | 12 | 0.040 |
Why?
|
| Introns | 1 | 2019 | 13 | 0.040 |
Why?
|
| Sequence Analysis, DNA | 1 | 2019 | 180 | 0.040 |
Why?
|
| Treatment Outcome | 1 | 2021 | 867 | 0.040 |
Why?
|
| Genetics | 1 | 2018 | 3 | 0.040 |
Why?
|
| Biological Evolution | 1 | 2018 | 9 | 0.040 |
Why?
|
| Genetic Techniques | 1 | 2018 | 9 | 0.040 |
Why?
|
| Evolution, Molecular | 1 | 2018 | 60 | 0.040 |
Why?
|
| Healthy Volunteers | 1 | 2017 | 18 | 0.040 |
Why?
|
| DNA Mutational Analysis | 1 | 2017 | 34 | 0.040 |
Why?
|
| Principal Component Analysis | 1 | 2017 | 20 | 0.040 |
Why?
|
| Database Management Systems | 1 | 2017 | 5 | 0.040 |
Why?
|
| Nigeria | 1 | 2017 | 40 | 0.040 |
Why?
|
| Pilot Projects | 1 | 2017 | 168 | 0.040 |
Why?
|
| Cross-Sectional Studies | 1 | 2022 | 1377 | 0.040 |
Why?
|
| Mutation | 1 | 2017 | 299 | 0.030 |
Why?
|
| Young Adult | 1 | 2021 | 2357 | 0.030 |
Why?
|
| Developing Countries | 1 | 2017 | 385 | 0.030 |
Why?
|
| Zebrafish | 1 | 2014 | 1 | 0.030 |
Why?
|
| Zebrafish Proteins | 1 | 2014 | 1 | 0.030 |
Why?
|
| Spatio-Temporal Analysis | 1 | 2014 | 14 | 0.030 |
Why?
|
| Spinal Cord Injuries | 1 | 2014 | 18 | 0.030 |
Why?
|
| Middle Aged | 1 | 2021 | 3425 | 0.030 |
Why?
|
| Animals | 1 | 2014 | 1063 | 0.020 |
Why?
|
| Adult | 1 | 2021 | 5664 | 0.020 |
Why?
|